Investors

We have strong financial and industrial shareholders.

Annual financial statements, quarterly reports and presentations.

Please contact our IR Contacts for any queries.

On 5 August 2019, FIL Limited disclosed additional purchase of shares in Ultimovacs bringing the total holding above 5%.